No Arabic abstract
The Oxford English Dictionary defines precision medicine as medical care designed to optimize efficiency or therapeutic benefit for particular groups of patients, especially by using genetic or molecular profiling. It is not an entirely new idea: physicians from ancient times have recognized that medical treatment needs to consider individual variations in patient characteristics. However, the modern precision medicine movement has been enabled by a confluence of events: scientific advances in fields such as genetics and pharmacology, technological advances in mobile devices and wearable sensors, and methodological advances in computing and data sciences. This chapter is about bandit algorithms: an area of data science of special relevance to precision medicine. With their roots in the seminal work of Bellman, Robbins, Lai and others, bandit algorithms have come to occupy a central place in modern data science ( Lattimore and Szepesvari, 2020). Bandit algorithms can be used in any situation where treatment decisions need to be made to optimize some health outcome. Since precision medicine focuses on the use of patient characteristics to guide treatment, contextual bandit algorithms are especially useful since they are designed to take such information into account. The role of bandit algorithms in areas of precision medicine such as mobile health and digital phenotyping has been reviewed before (Tewari and Murphy, 2017; Rabbi et al., 2019). Since these reviews were published, bandit algorithms have continued to find uses in mobile health and several new topics have emerged in the research on bandit algorithms. This chapter is written for quantitative researchers in fields such as statistics, machine learning, and operations research who might be interested in knowing more about the algorithmic and mathematical details of bandit algorithms that have been used in mobile health.
The complexity of human cancer often results in significant heterogeneity in response to treatment. Precision medicine offers potential to improve patient outcomes by leveraging this heterogeneity. Individualized treatment rules (ITRs) formalize precision medicine as maps from the patient covariate space into the space of allowable treatments. The optimal ITR is that which maximizes the mean of a clinical outcome in a population of interest. Patient-derived xenograft (PDX) studies permit the evaluation of multiple treatments within a single tumor and thus are ideally suited for estimating optimal ITRs. PDX data are characterized by correlated outcomes, a high-dimensional feature space, and a large number of treatments. Existing methods for estimating optimal ITRs do not take advantage of the unique structure of PDX data or handle the associated challenges well. In this paper, we explore machine learning methods for estimating optimal ITRs from PDX data. We analyze data from a large PDX study to identify biomarkers that are informative for developing personalized treatment recommendations in multiple cancers. We estimate optimal ITRs using regression-based approaches such as Q-learning and direct search methods such as outcome weighted learning. Finally, we implement a superlearner approach to combine a set of estimated ITRs and show that the resulting ITR performs better than any of the input ITRs, mitigating uncertainty regarding user choice of any particular ITR estimation methodology. Our results indicate that PDX data are a valuable resource for developing individualized treatment strategies in oncology.
The stochastic contextual bandit problem, which models the trade-off between exploration and exploitation, has many real applications, including recommender systems, online advertising and clinical trials. As many other machine learning algorithms, contextual bandit algorithms often have one or more hyper-parameters. As an example, in most optimal stochastic contextual bandit algorithms, there is an unknown exploration parameter which controls the trade-off between exploration and exploitation. A proper choice of the hyper-parameters is essential for contextual bandit algorithms to perform well. However, it is infeasible to use offline tuning methods to select hyper-parameters in contextual bandit environment since there is no pre-collected dataset and the decisions have to be made in real time. To tackle this problem, we first propose a two-layer bandit structure for auto tuning the exploration parameter and further generalize it to the Syndicated Bandits framework which can learn multiple hyper-parameters dynamically in contextual bandit environment. We show our Syndicated Bandits framework can achieve the optimal regret upper bounds and is general enough to handle the tuning tasks in many popular contextual bandit algorithms, such as LinUCB, LinTS, UCB-GLM, etc. Experiments on both synthetic and real datasets validate the effectiveness of our proposed framework.
We study a bandit version of phase retrieval where the learner chooses actions $(A_t)_{t=1}^n$ in the $d$-dimensional unit ball and the expected reward is $langle A_t, theta_starrangle^2$ where $theta_star in mathbb R^d$ is an unknown parameter vector. We prove that the minimax cumulative regret in this problem is $smash{tilde Theta(d sqrt{n})}$, which improves on the best known bounds by a factor of $smash{sqrt{d}}$. We also show that the minimax simple regret is $smash{tilde Theta(d / sqrt{n})}$ and that this is only achievable by an adaptive algorithm. Our analysis shows that an apparently convincing heuristic for guessing lower bounds can be misleading and that uniform bounds on the information ratio for information-directed sampling are not sufficient for optimal regret.
We discuss in this survey several network modeling methods and their applicability to precision medicine. We review several network centrality methods (degree centrality, closeness centrality, eccentricity centrality, betweenness centrality, and eigenvector-based prestige) and two systems controllability methods (minimum dominating sets and network structural controllability). We demonstrate their applicability to precision medicine on three multiple myeloma patient disease networks. Each network consists of protein-protein interactions built around a specific patients mutated genes, around the targets of the drugs used in the standard of care in multiple myeloma, and around multiple myeloma-specific essential genes. For each network we demonstrate how the network methods we discuss can be used to identify personalized, targeted drug combinations uniquely suited to that patient.
In this paper we propose the first multi-armed bandit algorithm based on re-sampling that achieves asymptotically optimal regret simultaneously for different families of arms (namely Bernoulli, Gaussian and Poisson distributions). Unlike Thompson Sampling which requires to specify a different prior to be optimal in each case, our proposal RB-SDA does not need any distribution-dependent tuning. RB-SDA belongs to the family of Sub-sampling Duelling Algorithms (SDA) which combines the sub-sampling idea first used by the BESA [1] and SSMC [2] algorithms with different sub-sampling schemes. In particular, RB-SDA uses Random Block sampling. We perform an experimental study assessing the flexibility and robustness of this promising novel approach for exploration in bandit models.